Top free apps for nurse practitioners

  • Oct. 19, 2023
APEA staff
Image Description

In today’s mobile world, we use apps for all kinds of reasons. Apps can help us keep track of our bank account, our favorite sports teams, and the whereabouts of family and friends. Apps can also help NPs and NP students find and apply essential information for the assessment and management of patients. Even better, many of these apps are free! The APEA nurse practitioner faculty recently shared some of their favorite free apps for clinical practice.

AHA Guidelines On-the-Go

The American Heart Association developed AHA Guidelines On-the-Go to provide healthcare professionals with mobile access to current cardiac health guidelines. The app provides information on complex clinical treatment guidelines, including the 2018 AHA guidelines on the following:

  • cholesterol (Chol)
  • heart attack (NSTEMI)
  • valvular heart disease (VHD)
  • heart failure update (HF)
  • dual antiplatelet therapy (DAPT)
  • peripheral artery disease (PAD)
  • recombinant tissue plasminogen activator (rTPA)
  • rehabilitation
  • percutaneous coronary intervention (PCI).

Each guideline contains an executive summary, “things to know,” patient education materials, risk assessments, and much more depending on the subject, condition, or disease. The AHA Guidelines On-the-Go app also provides interactive tools such as calculators, scores, and algorithms that help NPs plan a course of treatment effectively. Customer reviews report that the guidelines and tools are easy to use, helpful, and that the app has a user-friendly interface. AHA Guidelines On-the-Go is available for iOS and Android devices.


Created by Advanced Practice Education Associates, the APEA app allows users to access free materials and purchase APEA products. After purchasing an APEA product available at, open the app with your My Account login. Your purchases will automatically be synced to your device. The app allows you to:

  • watch multimedia courses via the CE Center, where you can earn contact hours and print your certificate
  • download and listen an audio review course while following each lecture in the course manual
  • easily access CareOnPoint, the mobile reference tool that contains content from the best-selling text, Clinical Guidelines in Primary Care
  • answer practice questions accessible with a MyQBank subscription
  • receive automatic notifications when new content is available
  • view your recent activity from the main menu
  • contact APEA via email directly from within the app.

An important feature of the APEA app is that you can access CE content downloaded to your device at any time, even without an internet connection. APEA is accredited by the American Association of Nurse Practitioners as an approved provider of continuing education for nurse practitioners.

An important note as of fall 2023: The APEA app is temporarily unavailable for Android devices. (It continues to be accessible on Apple devices.) However, our technology team is hard at work developing a completely revamped app that we expect to be available for Apple and Android devices in 2024.

ASCVD Risk Estimator Plus

Because atherosclerotic cardiovascular disease (ASCVD) has such a significant impact on the United States population, the American College of Cardiology (ACC) designed the ASCVD Risk Estimator Plus to help clinicians and patients develop a customized 10-year risk-lowering plan. According to the ACC, you can use the app to:

  • estimate a patient’s initial 10-year ASCVD risk using the pooled cohort equation
  • receive an individualized, risk-based, intervention approach for managing LDL-C and blood pressure
  • project the impact of specific interventions on a patient’s risk
  • guide clinician-patient discussion around customizing an intervention plan
  • update risk at follow-up based on a patient’s response to therapy using the Million Hearts Longitudinal model

Information contained in the app is derived from the ACC/AHA Guideline on the Management of Blood Cholesterol, the ACC/AHA Guideline on the Assessment of Cardiovascular Risk, the ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults, and the 2016 Million Hearts Longitudinal ASCVD Risk Assessment Tool user guide. The information and recommendations in this app are intended to support clinical decision making. They are not intended to represent the only or best course of care or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and provider. ASCVD Risk Estimator Plus is available for iOS and Android devices.

Aspirin Guide

For iOS, the Aspirin Guide app from researchers at Brigham and Women’s Hospital helps clinicians decide which patients are candidates for low-dose aspirin (75 mg/day to 81 mg/day) in the primary prevention of atherosclerotic cardiovascular disease (ASCVD) by balancing the ASCVD benefits against the risk of harm due to gastrointestinal or other bleeding. When using the app or the website, clinicians are presented with a series of questions and answers pertaining to their patient’s health. Aspirin Guide incorporates this information about the patient’s risk factors to calculate a 10-year ASCVD risk score (the ACC/AHA ASCVD score) and a bleeding risk score, which help NPs implement clinical guidelines on the use of aspirin in primary prevention. The app calculates a risk score and offers simple, quick input. It also allows the clinician to email a summary of the decision-making process to the patient.


This app was developed in 2005 by two physicians who wanted to make the diagnostic and decision making processes more efficient. The app provides 275 medical calculators that process algorithms and scores and assess risk "to make patients better, faster," the description states. Although it began as a medical calculator platform, the app's offerings now include a variety of evidence-based medicine tools. It can be used on multiple devices and integrated into the daily workflow of patient care. MDCalc is available for iOS and Android devices.

STD Tx Guide

The Centers for Disease Control and Prevention’s Division of STD Prevention developed the STD Treatment (Tx) Guidelines mobile app. The STD Tx Guide app helps providers access diagnostic information and current STD treatment guidelines as well as updates published in Morbidity and Mortality Weekly Reports. Providers who use this app receive quick access to the following information:

  • diagnosis and treatment of the most common STDs
  • diagnosis and treatment of sexual assault
  • list of commonly used terms and abbreviations
  • access to all current STD Treatment Guidelines
  • access to the CDC’s “A Guide to Taking a Sexual History”
  • push notifications for guideline updates.

The STD Tx Guide app is available for iOS and Android devices.


Developed by athenahealth, Epocrates is a drug interaction checker that is available for iOS and Android mobile devices. The app checks for drug-drug interactions among 30 drugs at a time. Interactions are categorized to help you determine the appropriate clinical action. According to the product description on iTunes, the app includes:

  • drug information - essential prescribing and safety information, including adult and pediatric dosing, adverse reactions, contraindications, boxed warnings, pregnancy and lactation considerations, etc.
  • formulary information - national and regional healthcare insurance formularies that identify copay tiers, quantity limits, step therapy guidelines, prior authorization requirements, and alternative drug choices
  • interaction check - clinically significant interactions among brand, generic, and OTC drugs and recommendations to mitigate potentially harmful effects
  • tables - concise quick-reference guides to find drug information on a wide range of topics, including ACLS protocols, drug class comparisons, endocarditis prophylaxis, vaccinations, Zika virus, and more
  • calculators - dosing calculators, medical equations and other tools
  • guidelines - patient-specific recommendations from a library of evidence-based clinical guidelines
  • pill identification - identify and verify drugs by imprint code, color, shape, or other attributes
  • notifications - brief summaries of news from the medical literature, as well as important updates from the CDC and FDA.

By upgrading to Epocrates Plus, users can also receive disease information, alternative medications, labs, ICD-10 codes, and other content.


GoodRx, through its healthcare provider mode, delivers information to clinicians to help their patients save up to 80% on medication prescriptions. The GoodRx app can be used on iOS and Android devices. Key features include:

  • quick identification of the form, dosage and quantity of a drug
  • a Favorites list of frequently prescribed medications. The app also sends prices to patients via email or text without revealing your contact information
  • news on drugs saved to your Favorites list
  • ability to order free GoodRx discount savings cards and brochures for patients.

No fees or signups are required for patients to save on prescriptions with GoodRx.

Monthly Prescribing Reference (MPR)

Monthly Prescribing Reference (MPR) is a multispecialty drug information resource for healthcare professionals that provides prescribing information, point-of-care tools, and news on hot topics in pharmacotherapy. According to the product description posted on iTunes, features of MPR include:

  • prescribing information for more than 4,300 prescription and OTC products, organized by therapeutic area and disease/condition
  • Quick Search function for drug information by brand name, generic name, disease/condition, or company
  • curated daily news on drug therapy and hot topics in medicine, customizable to scope of practice
  • breaking news notifications on safety alerts and recalls
  • automatic, real-time updates to prescribing information
  • clinical charts for quick product comparisons, as well as treatment algorithms and guidelines
  • medical calculators that simplify complex formulas, scores, and classifications.

An internet connection is not necessary to access prescribing information and tools. MPR is available for iOS and Android.

ACC Statin Intolerance

Created by the American College of Cardiology, the ACC Statin Intolerance app guides clinicians through the process of managing and treating patients who report muscle symptoms while on statin therapy. Clinicians can use the app to:

  • answer questions to evaluate possible intolerance to a patient's current statin prescription
  • follow steps to manage and treat a patient who reports muscle symptoms on a statin
  • compare statin characteristics and drug interactions to inform the management of LDL-related risk.

The information and recommendations in this app are derived from the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults and the prescribing information for each statin. The recommendations in this app are intended to support clinical decision making. They are not intended to represent the only or best course of care, or to replace clinical judgment. Therapeutic options should be determined jointly after a clinical evaluation and discussion between the patient and their provider. This app is available for free in the iTunes and Google Play app stores.

PneumoRecs VaxAdvisor

Created by the Centers for Disease Control and Prevention in collaboration with the Georgia Tech Research Institute, the PneumoRecs VaxAdvisor mobile app helps vaccination providers quickly and easily determine which pneumococcal vaccines a patient needs and when. The app incorporates recommendations for all ages. Users simply:

  • enter the patient’s age
  • note whether the patient has specific underlying medical conditions
  • answer questions about the patient’s pneumococcal vaccination history.

Afterward, the app provides patient-specific guidance consistent with the immunization schedule recommended by the U.S. Advisory Committee on Immunization Practices (ACIP). The app is available for iOS and Android devices.


Written by

APEA staff